Identification of secondary prevention patients eligible for PCSK9 inhibitors therapy according to the routine clinical practice in Spain

media

posted on 2023-05-15, 06:41 authored by Juan Cosin-Sales, Eduard Sidelnikov, Santiago Villamayor, Miriam Fernández, Sandra Merino-Montero, Alberto Zamora

The above graphical abstract represents the opinions of the authors. For a full list of declarations, including funding and author disclosure statements, please see the full text online (see “read the peer-reviewed publication” opposite).

History

Usage metrics

Keywords

acute cardiovascular events atherosclerotic cardiovascular disease cardiovascular disease PCSK9 inhibitors lipid lowering therapies

Licence

CC BY-NC 4.0

Identification of secondary prevention patients eligible for PCSK9 inhibitors therapy according to the routine clinical practice in Spain

History

Usage metrics

Categories

Keywords

Licence

Exports